The Conference Board analysts say the question isn’t why China will slow, but why anyone thinks it won’t
Tablets remain a problem in a record-breaking quarter
From Michael Dunn's trial in Florida to discord over open-carry laws in Colorado, the debate about gun control has driven Americans to indulge their worst behavior
The company misses earnings forecasts, drops its 2015 profit goal, and regroups
Chinese millionaires are moving in—and building up—in Arcadia, Calif.
A new book surveys the best places to hide out from the digital world
The two tech giants fight over market share and patents but not over the NBA superstar
Professor Piotr Naskrecki blogged about finding and killing one of the largest type of spider in the world, triggering a barrage of hate mail
Small businesses are changing hands at the fastest pace since the recession
Founder: Dr. Mark Pruzanski
VC Investment over the last four quarters: $25 million
Founded in 2002, the 25-employee biopharmaceutical company is in the process of developing therapeutic treatment of chronic fibrotic and metabolic diseases. Despite the downturn, the company raised significant funding this year. Sticking to a tight budget, Intercept expects to have enough cash resources to fund its operations until 2010.
Key to startup success: "Be persistent. Intercept was founded just before the last major downturn for biotech, which lasted through 2003 and venture capital completely dried up for new early-stage startups. [We] remained passionately dedicated to the company and persisted even though it took more than a year to secure financing."